AstraZeneca breast cancer drug combination gets USFDA okay Ruchika Sharma17 Nov 2023 11:37 AM ISTTruqap belongs to a class of drugs known as AKT inhibitors and works by targeting the AKT1 gene mutation, which is responsible for growth and...
Diabetes drug for prostate cancer? Columbia study provides clarity Dr. Kamal Kant Kohli16 Nov 2023 8:00 PM ISTIn the years since a 2005 study found that diabetes patients taking metformin had lower rates of cancer, oncologists have been excited by the prospect...
USFDA nod to Bristol Myers Squibb Augtyro for lung cancer Ruchika Sharma16 Nov 2023 5:30 PM ISTAugtyro is designed to minimize interactions that can lead to certain forms of treatment resistance in ROS1-positive metastatic NSCLC patients.
Dabur India's two units dismissed as defendants in hair relaxer lawsuit in US Ruchika Sharma16 Nov 2023 4:30 PM ISTDabur's unit Namaste Laboratories continues to be a defendant along with many other industry players such as L'Oreal, Revlon, Luster Products and...
Add on Docetaxel Improves Survival for Low-PSA Prostate Cancer Patients: JAMA Jacinthlyn Sylvia15 Nov 2023 6:30 PM ISTA recent study published in Journal of American Medical Association suggests that adding docetaxel to standard treatment could significantly improve...
Rznomics enters clinical trial collaboration with Roche to evaluate RZ-001 in combo with anti-PDL1 in liver cancer patients Ruchika Sharma15 Nov 2023 11:30 AM ISTSeongnam: Rznomics Inc., a South Korea based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, has...
New blood test could offer earlier detection of common deadly cancers Dr. Kamal Kant Kohli14 Nov 2023 4:30 PM ISTMost cancers become deadly by keeping a low profile, causing no symptoms until they're too advanced to treat. Ovarian and gastroesophageal cancers are...
Merck gets positive EMA Committee opinion for Keytruda plus Gemcitabine, Cisplatin for Biliary Tract Cancer Ruchika Sharma14 Nov 2023 2:00 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the European Medicines Agency's Committee for Medicinal...
Jubilant Radiopharma business receives ANDA approval for Technetium Sulfur Colloid Injection Ruchika Sharma14 Nov 2023 12:30 PM ISTNoida: Jubilant Pharmova Limited’s wholly owned subsidiary Jubilant Draximage Inc ('Company') has announced that it has received approval from...
Algorithm based on MRI features can predict liver cancer recurrence after resection Medha Baranwal14 Nov 2023 4:00 AM ISTChina: A model based on MRI features could help clinicians predict advanced-stage hepatocellular carcinoma (HCC) recurrence after patients have...
Gender-neutral HPV vaccination best at preventing cervical cancer Isra Zaman13 Nov 2023 9:30 AM ISTThe most effective way to prevent cervical cancer is to give HPV vaccines to both boys and girls, reports a collaborative study involving researchers...
Whole-body PET/CT predicts response to HER2-targeted therapy in metastatic breast cancer patients Dr. Kamal Kant Kohli12 Nov 2023 7:00 PM ISTA new imaging agent, 68Ga-ABY-025, can predict early metabolic response to human epidermal growth factor receptor 2 (HER2)-targeted treatment in...
